UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000005917 |
|---|---|
| Receipt number | R000006997 |
| Scientific Title | Feasibility study of Pemetrexed/Cisplatin/Bevacizumab and EGFR-TKIs in alternating cycles followed by Pemetrexed/Bevacizumab and EGFR-TKIs in alternating cycles as maintenance therapy for patients with stage IV EGFR mutation positive non-small-cell lung cancer |
| Date of disclosure of the study information | 2011/07/04 |
| Last modified on | 2016/05/11 15:43:28 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/07/04 17:51:39 | ||
| 2 | Update | 2011/07/07 11:18:17 | Public title Acronym |
|
| 3 | Update | 2011/07/07 11:26:06 | Narrative objectives1 |
|
| 4 | Update | 2011/07/07 12:45:20 | Interventions/Control_1 Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 5 | Update | 2016/05/11 15:43:28 | Recruitment status |
